Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion sales in 2023, it shows no signs ...

Novo Nordisk (NVO) reportedly plans to phase out production of human insulin pens while it ramps up production of other injected diabetes medications such as Ozempic. Read more.

Novo Nordisk, which manufactures weight-loss drug Wegovy and diabetes medication Ozempic, has asked the US authorities to ...

Researchers at the University of Copenhagen have developed a new weight-loss drug that may surpass the effectiveness of ...

While Novo Nordisk and Lilly are the undisputed leaders in weight management right now, a number of pharmaceutical companies ...

It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like ...

Scientists from the University of Copenhagen say they have developed a drug that decreases appetite while increasing calorie ...

A recent study that found there has been a massive increase in type 2 diabetes cases worldwide since 1990 is an indication ...

The company, headquartered in the key swing state of Pennsylvania, has announced the creation of 330 jobs in a significant ...

Renaissance Technologies, founded by the late Jim Simons, cuts its Tesla and Nvidia stakes while raising its GameStop ...

"We have seen an alarming rise in diabetes over the past three decades, which reflects the increase in obesity, compounded by the impacts of the marketing of unhealthy food, a lack of physical ...